donepezil has been researched along with Bladder, Overactive in 3 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The study included older adults (aged 65 and older) with a diagnosis of dementia using donepezil, galantamine, or rivastigmine." | 4.12 | Risk of overactive bladder associated with cholinesterase inhibitors in dementia. ( Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML; Masurkar, PP; Sherer, JT, 2022) |
| "Left middle cerebral artery occlusion (MCAO) was performed in female Sprague-Dawley rats." | 1.33 | Acetylcholinesterase inhibitor acting on the brain improves detrusor overactivity caused by cerebral infarction in rats. ( Akino, H; Aoki, Y; Ito, H; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Oyama, N; Shiyama, R; Tanase, K; Yokoyama, O, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Masurkar, PP | 1 |
| Chatterjee, S | 1 |
| Sherer, JT | 1 |
| Chen, H | 1 |
| Johnson, ML | 1 |
| Aparasu, RR | 1 |
| Sakakibara, R | 1 |
| Ogata, T | 1 |
| Uchiyama, T | 1 |
| Kishi, M | 1 |
| Ogawa, E | 1 |
| Isaka, S | 1 |
| Yuasa, J | 1 |
| Yamamoto, T | 1 |
| Ito, T | 1 |
| Yamanishi, T | 1 |
| Awa, Y | 1 |
| Yamaguchi, C | 1 |
| Takahashi, O | 1 |
| Nakai, M | 1 |
| Akino, H | 1 |
| Kaneda, T | 1 |
| Matsuta, Y | 1 |
| Shiyama, R | 1 |
| Tanase, K | 1 |
| Ito, H | 1 |
| Aoki, Y | 1 |
| Oyama, N | 1 |
| Miwa, Y | 1 |
| Yokoyama, O | 1 |
3 other studies available for donepezil and Bladder, Overactive
| Article | Year |
|---|---|
Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Humans; Male; Medicare; M | 2022 |
How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central acetylcholinesterase inhibitor, and propiverine, a peripheral muscarine receptor antagonist.
Topics: Aged; Aged, 80 and over; Benzilates; Chi-Square Distribution; Cholinergic Antagonists; Cholinesteras | 2009 |
Acetylcholinesterase inhibitor acting on the brain improves detrusor overactivity caused by cerebral infarction in rats.
Topics: Analysis of Variance; Animals; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Donepe | 2006 |